Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 fold » _ fold (Expand Search)
Showing 1,781 - 1,800 results of 99,932 for search '(( 5 fold decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.62s Refine Results
  1. 1781
    AQP4 abundance.

    AQP4 abundance. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  2. 1782
    Inner medullary expression of AQP2 and p-AQP2.

    Inner medullary expression of AQP2 and p-AQP2. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  3. 1783
    (Pro)renin receptor abundance.

    (Pro)renin receptor abundance. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  4. 1784
    Inner medullary expression of AQP3 and Na-K-ATPase.

    Inner medullary expression of AQP3 and Na-K-ATPase. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  5. 1785
    Post treatment echocardiagraphic parameters.

    Post treatment echocardiagraphic parameters. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  6. 1786
    AQP2 and p-AQP2 abundance.

    AQP2 and p-AQP2 abundance. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  7. 1787
    Inner medullary expression of AQP1.

    Inner medullary expression of AQP1. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  8. 1788
    Gsα subunit abundance.

    Gsα subunit abundance. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  9. 1789
    Pretreatment echocardiagraphic parameters.

    Pretreatment echocardiagraphic parameters. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  10. 1790
    Inner medullary expression of the (pro)renin receptor.

    Inner medullary expression of the (pro)renin receptor. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  11. 1791
    Diagram of study design.

    Diagram of study design. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  12. 1792
    Type 1<sub>A</sub> angiotensin II receptor abundance.

    Type 1<sub>A</sub> angiotensin II receptor abundance. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  13. 1793
    Inner medullary expression of AQP4.

    Inner medullary expression of AQP4. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  14. 1794
    Changes in renal function.

    Changes in renal function. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  15. 1795
    Inner medullary expression of the type 1<sub>A</sub> angiotensin II receptor.

    Inner medullary expression of the type 1<sub>A</sub> angiotensin II receptor. by Sophie Constantin Lütken (689916)

    Published 2015
    Subjects:
    Save to List
    Saved in:
  16. 1796
    BafA1 attenuates PtdIns3P elevation but does not ameliorate PtdIns(3,5)P<sub>2</sub> reduced by YM201636.

    BafA1 attenuates PtdIns3P elevation but does not ameliorate PtdIns(3,5)P<sub>2</sub> reduced by YM201636. by Diego Sbrissa (2653723)

    Published 2018
    “…YM201636 decreased PtdIns5P and PtdIns(3,5)P<sub>2</sub> and both remained similarly reduced by pretreatment with BafA1. …”
    Save to List
    Saved in:
  17. 1797
    Fig 5 -

    Fig 5 - by Arjen Tilstra (6915227)

    Published 2023
    Save to List
    Saved in:
  18. 1798
    Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b - Fig 1

    Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b - Fig 1 by Nobuyuki Matsumoto (239090)

    Published 2016
    Subjects:
    Save to List
    Saved in:
  19. 1799
    Structure of YOLOv5s-SBC.

    Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

    Published 2024
    “…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”
    Save to List
    Saved in:
  20. 1800
    SARS-CoV-2 inhibits SG formation and decreases expression of G3BP1.

    SARS-CoV-2 inhibits SG formation and decreases expression of G3BP1. by Stacia M. Dolliver (13822801)

    Published 2022
    Save to List
    Saved in:

Search Tools: